Epic Research is a leading financial services provider with presence in Indian and other global capital markets. With its full fledged research operations, Epic Research has proven itself as Investment Advisory Company that produces and delivers high accuracy tips and recommendations for StockTips, Commodity Tips, Forex Tips.

1. Daily Equity Report (1 Mar 2012)
Daily market
 Indian equity markets were up 0.18%.
 Nifty up 9pts and settle at 5385.
 Sensex was up 21pts at 17752.
 Bank Nifty down 110pts at 10519.
Global market
 European markets were in green with FTSE up 11pts at 5939, CAC up 30pts at
3484 and DAX up 67pts at 6955.
 Dow future up 33pts at 13030.
 USD Trade Balance came at (-) 48.8B Vs (-) 47.8B
Fiis & Diis
CATAGERY DATE BUY SELL NET
FII 29-Feb-2012 3666.24 3086.61 579.63
DII 29-Feb-2012 1113.77 1544.84 -431.07

2. www.epicresearch.co +919993959693
Daily Nifty Gainers
COMPANY CURR.RATE VOL PREV.CL NET CHANGE CHANGE%
ONGC 293.20 8905.41 283.40 9.80 3.46
SAIL 103.15 6226.96 99.75 3.40 3.41
Ril 820.75 6365.25 796.50 24.25 3.04
Sesa Goa 214.40 4209.27 208.10 6.30 3.03
Wipro 432.35 1156.32 420.25 12.10 2.88
Daily Nifty Losers
COMPANY CURR.RATE VOL PREV.CL NET CHANGE CHANGE%
L&T 1308.05 4112.51 1348.80 -3.02 -40.75
HDFC Bank 517.10 4997.16 530.50 -2.53 -13.40
Siemens 796.25 100.58 811.50 -1.88 -15.25
JSPL 582.75 3288.11 593.65 -1.84 -10.90
ITC 207.65 8858.53 210.70 -1.45 -3.05
NIFTY Daily pivots
Pivot R4 R3 R2 R1 PP S1 S2 S3 S4
Nifty 5716 5610 5504 5445 5398 5339 5292 5186 5080
Stock in ban period Stocks to watch
 ABGSHIP  SESA GOA
 DLF
 L&T
 BHEL
 TATA MOTORS
www.epicresearch.co +919993959693

3. www.epicresearch.co +919993959693
Nifty Daily Chart
Bank Nifty Daily Chart
www.epicresearch.co +919993959693

4. www.epicresearch.co +919993959693
Disclaimer
The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not
accept any responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits
them the most.
Sincere efforts have been made to present the right investment perspective. The information contained herein is based on
analysis and up on sources that we consider reliable.
This material is for personal information and based upon it & takes no responsibility
The information given herein should be treated as only factor, while making investment decision. The report does not
provide individually tailor-made investment advice. Epic research recommends that investors independently evaluate
particular investments and strategies, and encourages investors to seek the advice of a financial adviser. Epic research shall
not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules
and regulations of NSE and BSE.
The share price projections shown are not necessarily indicative of future price performance. The information herein,
together with all estimates and forecasts, can change without notice. Analyst or any person related to epic research might be
holding positions in the stocks recommended. It is understood that anyone who is browsing through the site has done so at
his free will and does not read any views expressed as a recommendation for which either the site or its owners or
anyone can be held responsible for . Any surfing and reading of the information is the acceptance of this disclaimer.
All Rights Reserved.
Investment in equity & bullion market has its own risks.
We, however, do not vouch for the accuracy or the completeness thereof. we are not responsible for any loss incurred
whatsoever for any financial profits or loss which may arise from the recommendations above epic research does not
purport to be an invitation or an offer to buy or sell any financial instrument. Our Clients (Paid Or Unpaid), Any third party or
anyone else have no rights to forward or share our calls or SMS or Report or Any Information Provided by us to/with anyone
which is received directly or indirectly by them. If found so then Serious Legal Actions can be taken.
www.epicresearch.co +919993959693